导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 18.86% | 227/1050 |
| 近一周 | -2.24% | 874/1104 |
| 近一月 | -2.28% | 152/1103 |
| 近一季 | -1.65% | 338/1094 |
| 近半年 | 13.87% | 232/1074 |
| 近一年 | 35.12% | 138/1020 |
| 近两年 | 79.18% | 311/926 |
| 近三年 | 82.38% | 123/834 |
| 成立以来 | 90.20% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.33% 312/1070 |
20.05% 389/1101 |
- - |
- - |
| 2025 | 40.31% 321/1065 |
-0.31% 812/1014 |
2.81% 451/1038 |
24.15% 470/1050 |
10.28% 43/1065 |
| 2024 | 9.64% 300/1011 |
7.00% 60/960 |
4.31% 126/983 |
0.38% 952/991 |
-2.13% 461/1011 |
| 2023 | -4.64% 196/952 |
5.61% 283/880 |
-9.55% 753/895 |
-0.34% 97/915 |
0.17% 115/952 |
| 2022 | -27.11% 553/867 |
-7.65% 60/773 |
0.39% 689/806 |
-9.53% 217/845 |
-13.08% 824/867 |
| 2021 | -4.69% 410/740 |
-0.45% 168/580 |
1.59% 520/659 |
-7.43% 436/704 |
1.81% 363/740 |
| 2020 | 35.97% 325/554 |
-3.84% 260/419 |
10.55% 395/466 |
13.16% 175/517 |
13.04% 252/554 |
| 2019 | 55.62% 107/410 |
20.33% 911/1146 |
15.31% 1/1228 |
1.47% 291/390 |
10.54% 147/410 |
| 2018 | -31.14% 232/349 |
- - |
0.44% 69/990 |
-14.63% 941/1000 |
-14.69% 867/1080 |
| 2017 | 32.97% 29/285 |
- - |
- - |
- - |
- - |
| 2016 | -14.99% 92/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 前海开源优势蓝筹股票A VS. 东吴新产业精选股票A(580008) |